NCT04384601View on ClinicalTrials.gov

Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

September 30, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2027

Conditions
Gastric CancerNeoadjuvant Chemotherapy
Interventions
DRUG

Chemotherapy

Perioperative chemotherapy will be administered according to description in two arms.

Trial Locations (1)

200025

Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER

NCT04384601 - Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer | Biotech Hunter | Biotech Hunter